Laboratory Investigation of Cardiac Disease Flashcards

1
Q
  1. List 5 biochemical tests used in clinical medicine?
A
  1. Screening ( subclinical conditions that are not recognisable in clinical findings)
  2. Diagnosis (abnormal vs normal)
  3. Monitoring ( course of disease)
  4. Clinical management (treatment/response)
  5. Prognosis (risk stratification - classification into group depending on risk levels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. What is a biomarker?
A

A substance which allows identification of the disease and measure of treatment effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What are two analytical characteristics of an ideal biomarker?
A
  • Measurable by cost-effective method and simple to perform.
  • Rapid turnaround time with sufficient precision & accuracy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. What are five clinical characteristics of an ideal biomarker?
A
  • Early detection of disease and the ability to improve patient outcome
  • Sensitivity vs specificity
  • Validated decision limits
  • Selection of therapy
  • Risk stratification and Prognostic value (information about overall likely outcome of disease).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Cardiovascular disease is an umbrella term for other lil diseases- give some examples of what diseases these would be?
A

• coronary heart disease (CHD), cerebrovascular disease, peripheral arterial disease, rheumatic and congenital heart diseases, venous thromboembolism and lymphatic disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. What % of deaths are caused by cardiovascular disease?
A

1/4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. Fill in the blank”

Every * minutes , someone dies from cardiovascular disease”

A

8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. What is the total healthcare cost of cardiovascular disease?
A

9 Billion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Coronary heart diseases causes the most deaths in men and women , how?
A

Myocardial Infarction

Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. How does an atheromatous plaque develop?
A
  1. Foam Cells ( macrophages) localise to fatty deposits on blood vessels wall and infiltrate
  2. Lipids accumulate forming lipid cores , –> surface defects, thrombosis and sometimes haemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. What % of the age groups below have a risk of getting significant coronary atherosclerosis (build-up of plaques):
    <20 year olds
    20-29 year olds
    30-39 year olds
A

20% in <20 year olds,
50% in 20-29 year olds and
up to 65% in 30-39 year olds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Describe the initiation of Atherosclerosis?
A

LDL penetrates the endothelium–>oxidative modification—> releases pro inflammatory lipids–> surface now expresses adhesion molecules –>surface monocytes adhere to–>Monocytes then enter the intima and respond to the cytokines–>M-CSF -> monocytes = macrophages–>upregulate expression of surface receptors–> release of proinflammatory mediators–> Receptors mediate the uptake of oxidised LDL–>cholesterol accumulation in the cell which then develops into a foam cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. What does M-CSF stand for?
A

macrophage colony stimulating factor - cytokine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. What is the main consequence of Coronary Thrombosis?
A

Ischaemia (decreased blood flow due to plaque build-up in the coronary arteries) can become necrosis (dead tissue). This can cause myocardial infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Explain the whole process of atherosclerosis in simple terms?
A
  1. Irritant (LDL, Toxins)
  2. Irritant disrupts endothelium
  3. Cholesterol build up (fatty streak) in damaged wall
  4. LDL oxidised
  5. Sends signals which cause monocytes to arrive
  6. M-CSF converts monocytes to macrophages
  7. Macrophages try to engulf LDL, become foam cells and die, release cytokines
  8. Smooth muscle cells form fibrous cap around plaque and release calcium (makes plaque hard)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. How can a plaque rupture lead to myocardial infarction?
A

o A plaque with a fibrous cap (muscle cells, foam cells, collagen/elastin etc) causes angina.
o When the cap ruptures and LDL is released, it causes acute coronary syndromes.
o A blood clot forms around the cap rupture, this blocks the artery and causes heart attack.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  1. Why is it important to define the type of ischaemic heart disease?
A

oIt is important to differentiate between stable angina and acute myocardial infarction because this determines the treatment, prognosis and management needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. What are some causes of chest pain?
A

o Broken ribs, collapsed lungs or ‘pulled’ muscles.
o Nerve infection (shingles) or other infections.
o Pericarditis (inflammation of the pericardium) or blood clot in the lungs (PE).
o Heart burn (hernia) or angina or myocardial infarction.
o Areas of radiation pain: neck, jaw, upper abdomen, shoulders or arms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. What kind of assessments would you do for a patient with Ischaemia heart disease?
A

Medical history, Risk factors, Presenting signs/symptoms, ECG, Imaging/Scans and Biomarkers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. What can biochemical markers of cardiac damage contribute to?
A
o	Rule in/out an acute MI 
o	Confirm an old MI 
o	Help to define therapy and monitor success of therapy 
o	Diagnosis of heart failure 
o	Risk stratification of death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  1. What does irreversible myocardial injury require?
A

Irreversible injury typically requires 30 minutes of ischaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

22.How long does it take after damage for 80% of cardiac cells to die ? How about 100% of cells?

A

o High risk that 80% of cardiac cells die within 3 hours and almost 100% by 6 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
  1. During myocardial injury you may have cellular content leak out through membrane . What does this depend on?
A

Size

Solubility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
  1. Why is the concentration gradient of cellular compartments inside to outside the myocardial cells important?
A

high gradient improves detection of early damage

25
Q

25, What are some markers of myocardial damage’?

A

o After Mi, there is a 7-36 h peak in heart muscles specific markers troponin-T and troponin-I.
o Creatine kinase (Increase of 90% MIs, but less specific as also released from skeletal muscle).
o Heart specific isoforms of creatine phosphokinase (CPK-MB).
o Myoglobin raised early but less specific for heart damage.

26
Q
  1. For the serum protein CREATINE KINASE :
    - How long does it take to elevate for the 1st time after infarction
    - How long does it take for its peak elevation??
    - What is the duration of elevation?
A
  • 4-6 hours
  • 18-36 hours
  • 3 days
27
Q
  1. For the serum protein MYOGLOBIN :
    - How long does it take to elevate for the 1st time after infarction
    - How long does it take for its peak elevation??
    - What is the duration of elevation?
A
  • 2-3 hours
  • 6-9 hours
  • 1 day
28
Q
  1. For the serum protein TROPONIN I & T :
    - How long does it take to elevate for the 1st time after infarction
    - How long does it take for its peak elevation??
    - What is the duration of elevation?
A
  • 4-6 Hours
  • 24-36 hours
  • duration depends on extent of damage
29
Q
  1. What is the troponin complex a component of?
A

o The troponin complex is a component of the thin filaments in striated muscle complexed to actin.

30
Q
  1. How are troponin different to each other?
A

different proteins, structurally unrelated

31
Q
  1. What are the three types of troponin and what is their function?):
A
Troponin T (tropomyosin binding),
 Troponin I (inhibits actomyosin ATPase), 
Troponin C (calcium binding).
32
Q
  1. Fill in the blank “ Cardiac troponin T and I differ significantly from troponin **”
    - CHECK THIS -
A

T

  • CHECK THIS-
  • DOESN’T MAKE SENSE-
33
Q
  1. Which muscle would we find Troponin I?
A

Skeletal Muscle

34
Q
  1. What are 3 clinical advantages of cardiac troponin?
A

An index of cardiac damage

Blood levels related to severity of cardiac damage

Predicts major adverse cardiac events such as myocardial infarction

35
Q
  1. What type of test do we use to detect troponin?
A

ELISA

Enzyme linked immunosorbent assay

36
Q
  1. Explain how an ELISA tests work?
A
  1. Immobilised Capture antibody
  2. Add patient sample
  3. Detecting antibody
  4. Any “Troponin” in the patient sample will bind with capture antibodies and detecting antibodies- now immobilised
  5. Well is washed
  6. Signal is added that binds with detecting antibody-so we can see how much troponin in the sample
37
Q
  1. What is heart failure?
A

o A complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood.

38
Q
  1. How many people in the UK are living with heart failure?
A

920,000 people living with heart failure in the UK

39
Q
  1. What is the prevalence of heart failure?
A

1-2% of men and women

40
Q
  1. What is the prognosis for heart failure?
A

1 year survival

50%

41
Q
  1. What are some major causes of heart failure?
A
  • Coronary Artery Disease
  • Chronic Hypertension
  • Cardiomyopathy
  • Heart Valve Disease
  • Arrhythmias- AF,VT
  • Infective endocarditis
  • Pulmonary Hypertension- PE, COPD
  • Alcohol and Drugs (e.g. cocaine).
42
Q
  1. What are some signs and symptoms of congestive heart failure?
A
  • Shortness of breath
  • Lack of energy
  • Swelling of legs and feet
  • Chronic lack of energy
  • Swollen or tender abdomen with loss of appetite
  • Cough with frothy sputum
  • Increased urination at night
  • -Difficulty to sleep at night because of breathing problems
  • Confusion/impaired memory
43
Q
  1. Are the signs and symptoms for cardiac heart failure very quick and easy to spot and then diagnose cardiac heart failure?
A

o Sensitivity and specificity of signs and symptoms of heart failure is relatively poor.

44
Q
  1. What is the clinical utilisation of cardiac biomarker testing in heart failure ?
A

oInitial evaluation of heart failure.
oScreening for cardiac dysfunction
oGuiding management of heart failure.
oThe assessment of prognosis and survival

45
Q
  1. What types of peptides are markers of cardiac overload?
A

Natriuretic Peptides

46
Q
  1. What are the names of the ABC markers?
A

-ANP
-BNP
-CNP
(A,B,C natriuretic peptide..)

47
Q
  1. Name the source for the following natriuretic peptides:
    - ANP
    - BNP
    - CNP
A
  • ANP = ATRIUM
  • BNP = VENTRICLE
  • CNP= ENDOTHELIAL
48
Q
  1. What form are all peptides synthesised as?
A

HMW Precursor

49
Q
  1. What are the main effects of the following peptides:
    -ANP
    -BNP
    -CNP
    ??
A

ANP + BNP :

  • Natriuretic (sodium excretion in the urine)
  • Vasorelaxant
  • RAAS inhibition (decreases sodium reabsorption)

CNP:

  • Vasorelaxant
  • CNS effects
50
Q
  1. What is the stimulus that causes the secretion of ANP and BNP?
A

ANP:
-Atrial Stretch

BNP:
=Ventricular dilation

51
Q
  1. What kind of function do these peptides (A,B,C) have . Endocrine, autocrine or paracrine
A

ANP:
-Endocrine

BNP:
-Endocrine

CNP:
-Paracrine

52
Q
  1. How do we measure the patient plasma for natriuretic peptides?
A

o Assays available for the active peptides and the N-terminal precursor forms of BNP.

53
Q
  1. What are some advantages of measuring for the N -terminal precursor forms of BNP?
A
  • Longer half-life so higher plasma concentrations

* Less sensitive to rapid fluctuations

54
Q
  1. Why would we measure for plasma BNP- What can it tell us?
A

o Assessment of severity and monitoring the response to a treatment in congestive heart failure
o Screening for mild heart failure
o Prognostic outcome/risk stratification
o Higher proBNP: Higher probability/risk of heart failure.

55
Q
  1. What values of BNP and NT-proBNP would indicate a high probability of HF?
A

BNP >500 pg/ml

NT-proBNP >1800 pg/ml

56
Q

56.What values of BNP and NT-proBNP would indicate an intermediate probability of HF?

A

BNP 100-400 pg/ml

NT-proBNP 300-1800 pg/ml

57
Q
  1. What values of BNP and NT-proBNP would indicate an low probability of HF?
A

BNP <100 pg/ml

NT-proBNP <300 pg/ml

58
Q
  1. If troponin I increases hours after cardiac damage, what is it a sign off?
A

MI